1.
Arnason BGW, Soliven B: Acute inflammatory demyelinating polyradiculopathy; in Dyck PJ, Thomas PK, Griffin JW (eds): Peripheral Neuropathy, ed 3. Philadelphia, Saunders, 1993, pp 1437–1497.
2.
Ropper AH: The Guillain-Barré syndrome. N Engl J Med 1992;326:1130–1135.
3.
Olbricht CJ, Stark E, Helmchen U, Brunkhorst R, Koch KM: Glomerulonephritis associated with inflammatory demyelinating polyradiculoneuropathy. A case report and review of the literature. Nephron 1993;64:139–141.
4.
Moore PM, Fauci AS: Neurologic manifestations of systemic vasculitis: A retrospective and prospective study of the clinicopathologic features and responses to therapy in 25 patients. Am J Med 1981;71:517–524.
5.
Bouch P, Leger JM, Travers MA: Peripheral neuropathy in systemic vasculitis: Clinical and electrophysiologic study of 22 patients. Neurology 1986;36:1598–1602.
6.
Chalk CH, Homburger HA, Dyck PJ: Anti-neutrophil cytoplasmic antibodies in vasculitic neuropathies. Neurology 1993;43:1826–1827.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or...
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.